Depressive Disorder: all 4,847 studies

Page 12 of 49. Open to participants first (509), then studies with results posted, then the rest; newest registration first within each.

• SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension StudyTerminatedNCT01436175Phase 3Results posted
• Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderCompletedNCT01436162Phase 3Results posted
• Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderCompletedNCT01436149Phase 3Results posted
• SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderCompletedNCT01435759Phase 2Results posted
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)CompletedNCT01432457Phase 4Results posted
• Wake Therapy in the Treatment of DepressionCompletedNCT01431573Not applicableResults posted
• Tranylcypromine Treatment of Bipolar DepressionCompletedNCT01430455Phase 4Results posted
• Minocycline and Aspirin in the Treatment of Bipolar DepressionCompletedNCT01429272Phase 3Results posted
• Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive DisorderCompletedNCT01428661Phase 2/3Results posted
• Sustaining Remission of Psychotic DepressionCompletedNCT01427608Phase 4Results posted
• Pharmacogenomics for Antidepressant Guidance and Education 1 (PAGE-1_AG1)TerminatedNCT01426516Not applicableResults posted
• Major Depressive Disorder With Mixed Features - ExtensionCompletedNCT01423253Phase 3Results posted
• Efficacy Study of Vortioxetine on Cognitive Dysfunction in Adult Patients With Major Depressive DisorderCompletedNCT01422213Phase 3Results posted
• VA Augmentation and Switching Treatments for Improving Depression OutcomesCompletedNCT01421342Phase 3Results posted
• Major Depressive Disorder (MDD) With Mixed Features - Flexible DoseCompletedNCT01421134Phase 3Results posted
• Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive DisorderCompletedNCT01415154Not applicableResults posted
• Study Using Pregnenolone to Treat Bipolar DepressionCompletedNCT01409096Phase 4Results posted
• Buprenorphine for Treatment Resistant DepressionCompletedNCT01407575Phase 3Results posted
• Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for DepressionCompletedNCT01407094Phase 2Results posted
• Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar DepressionCompletedNCT01396447Phase 2Results posted
• The Treatment of Depression With Botulinum Type A ToxinCompletedNCT01392963Phase 2Results posted
• Exploring the Effects of Coenzyme Q10 on Bioenergetics Metabolism in Geriatric Bipolar DepressionCompletedNCT01390389Not applicableResults posted
• A Study to Evaluate the Effect of Food on LY2216684CompletedNCT01389765Phase 1Results posted
• A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy SubjectsCompletedNCT01389752Phase 1Results posted
• A Study of LY2216684 in Healthy ParticipantsCompletedNCT01380691Phase 1Results posted
• Behavioral Change in the Mother-Infant Dyad: Preventing Postpartum DepressionCompletedNCT01379781Not applicableResults posted
• Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive DisorderCompletedNCT01377194Phase 3Results posted
• A Study of LY2216684 in Healthy FemalesCompletedNCT01373931Phase 1Results posted
• Trial of Collaborative Depression Care Management for HIV PatientsCompletedNCT01372605Not applicableResults posted
• A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDDCompletedNCT01372150Phase 3Results posted
• A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDDCompletedNCT01371734Phase 3Results posted
• A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDDCompletedNCT01371721Phase 3Results posted
• A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDDCompletedNCT01371708Phase 3Results posted
• A Study of LY2216684 in Participants With Major Depression DisorderCompletedNCT01370499Phase 3Results posted
• Deplin® P.L.U.S. Program (Progress Through Learning Understanding & Support)CompletedNCT01369030Results posted
• Lexapro for the Treatment of Traumatic Brain Injury (TBI) Depression & Other Psychiatric ConditionsCompletedNCT01368432Phase 2Results posted
• Ketamine Anesthesia in Electroconvulsive TherapyCompletedNCT01367119Not applicableResults posted
• Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual DysfunctionCompletedNCT01364649Phase 3Results posted
• Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)CompletedNCT01360866Phase 3Results posted
• Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)CompletedNCT01360645Phase 3Results posted
• Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)CompletedNCT01360632Phase 3Results posted
• The Effect of Melatonin on Depression, Anxiety, Cognitive Function and Sleep Disturbances in Breast Cancer PatientsTerminatedNCT01355523Phase 2/3Results posted
• Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive DisorderCompletedNCT01355081Phase 3Results posted
• Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino PatientsTerminatedNCT01353963Results posted
• Paxil CR Bioequivalence Study Brazil - Fed AdministrationCompletedNCT01339247Phase 1Results posted
• Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive DisorderTerminatedNCT01337609Phase 4Results posted
• European Deep Brain Stimulation (DBS) Depression StudyCompletedNCT01331330Not applicableResults posted
• Efficacy and Safety of Cranial Electrical Stimulation (CES) for Major Depressive Disorder (MDD)CompletedNCT01325532Not applicableResults posted
• Open-label Safety Extension Study of 15 and 20 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in AdultsCompletedNCT01323478Phase 3Results posted
• Investigation on the Value of Bilateral Index (BIS) Monitoring for Magnetic Seizure Versus Electroconvulsive TherapyCompletedNCT01318018Results posted
• Paxil CR Bioequivalence Study BrazilCompletedNCT01316926Phase 1Results posted
• Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)CompletedNCT01312922Phase 3Results posted
• Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in DepressionTerminatedNCT01309581Not applicableResults posted
• Perimenopausal Estrogen Replacement Therapy StudyCompletedNCT01308814Phase 2/3Results posted
• Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderCompletedNCT01305408Phase 3Results posted
• Intranasal Ketamine in Treatment-Resistant DepressionCompletedNCT01304147Not applicableResults posted
• A Study in Prevention of Re-emergence of Depression SymptomsCompletedNCT01299272Phase 3Results posted
• A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.TerminatedNCT01288079Phase 2Results posted
• Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I DepressionCompletedNCT01284517Phase 3Results posted
• A Study of the Effect of LY2216684 on LorazepamCompletedNCT01275144Phase 1Results posted
• Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) StudyCompletedNCT01269710Results posted
• A Study of LY2216684 and Digoxin in Healthy SubjectsCompletedNCT01266590Phase 1Results posted
• A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake InhibitorsCompletedNCT01263223Phase 1Results posted
• A Study of LY2216684 in Healthy Participants Receiving Albuterol or PropanololCompletedNCT01263197Phase 1Results posted
• A Study of LY2216684 and Warfarin in Healthy SubjectsCompletedNCT01263119Phase 1Results posted
• A Study of LY2216684 and Theophylline in Healthy SubjectsCompletedNCT01263106Phase 1Results posted
• A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of ClopidogrelCompletedNCT01263093Phase 1Results posted
• N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major DepressionTerminatedNCT01260649Phase 4Results posted
• Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar DepressionCompletedNCT01256177Phase 3Results posted
• Intervention Study of Depression in Breast Cancer PatientsCompletedNCT01256008Not applicableResults posted
• Efficacy and Safety Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive DisorderCompletedNCT01255787Phase 2/3Results posted
• Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Adults With Fatigue Associated With Major Depressive DisorderCompletedNCT01254305Phase 2Results posted
• The Effects of Dopamine on Reward ProcessingCompletedNCT01253421Phase 1Results posted
• A Pharmacokinetic Study of the Coadministration of LY2216684 With SertralineCompletedNCT01250873Phase 1Results posted
• Lexapro for Major Depression in Patients With EpilepsyTerminatedNCT01244724Phase 4Results posted
• Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for BenzodiazepinesTerminatedNCT01244711Phase 4Results posted
• A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together.CompletedNCT01243957Phase 1Results posted
• A Study of LY2216684 in Participants With Impaired Hepatic FunctionCompletedNCT01241435Phase 1Results posted
• Feasibility Study of Duloxetine in the Treatment of Depression in Patients With Traumatic Brain InjuryTerminatedNCT01223001Phase 2Results posted
• Oxytocin Add-on for Stable Depressed PatientsTerminatedNCT01211756Not applicableResults posted
• Treating Major Depression With Yoga: A Prospective, Randomized Controlled Pilot TrialCompletedNCT01210651Not applicableResults posted
• Efficacy and Tolerability of Riluzole in Treatment Resistant DepressionCompletedNCT01204918Phase 2Results posted
• A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac PatientsCompletedNCT01201967Phase 4Results posted
• Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive DisorderCompletedNCT01198795Phase 4Results posted
• A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.CompletedNCT01197508Phase 3Results posted
• Building Recovery By Improving Goals, Habits, and ThoughtsCompletedNCT01191788Not applicableResults posted
• The Effectiveness of rTMS in Depressed VA PatientsCompletedNCT01191333Not applicableResults posted
• Phase 1 Study To Test the Bioequivalence Between Two 25 mg Tablets vs. One 50 mg Tablet Under Fast/Fed Condition and Evaluate Food Effect of Desvenlafaxine Succinate Sustained Release (DVS SR)CompletedNCT01190514Phase 1Results posted
• Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder SymptomsCompletedNCT01189812Phase 2Results posted
• A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) TreatmentCompletedNCT01187407Phase 3Results posted
• A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake InhibitorCompletedNCT01185340Phase 3Results posted
• Epigenetic Regulation of BDNF in Major DepressionCompletedNCT01182103Results posted
• A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive DisorderCompletedNCT01180400Phase 3Results posted
• Safety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCompletedNCT01179516Phase 3Results posted
• Treatment Resistant Depression (Pilot)CompletedNCT01179009Not applicableResults posted
• A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive DisorderCompletedNCT01173601Phase 3Results posted
• Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive DisorderCompletedNCT01168674Phase 4Results posted
• Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCompletedNCT01163266Phase 3Results posted
• Repetitive Transcranial Magnetic Stimulation for Treating Depression: A Functional Magnetic Resonance Imaging StudyTerminatedNCT01162382Not applicableResults posted
• A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)CompletedNCT01157078Phase 3Results posted

← Depressive Disorder overview